China’s 3SBio seeks US$400 million in Hong Kong to boost drug pipeline

--------------------------------------------------------------------
Source: South China Morning Post
Published: 2025-12-02 14:47 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Asia, China, Financial Markets, Drugs, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
Share placement to help Shenyang-based firm advance clinical research in China and the US, expand reach of cancer and hair-loss drugs
--------------------------------------------------------------------
>>> Read full article at South China Morning Post <<<
<-- Back to Home
< >
[Close]